Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ESTEVE CDMO announced that it would add to its plans for the buildout of a new production unit at its facility in Celrà and launch a new brand identity.
read more
LGM Pharma has announced the second phase of its CDMO growth strategy, committing an additional $9 million to its drug product manufacturing facilities in Rosenberg, Texas, and Colorado Springs, Colorado.
read more
Cellipont Bioservices announced a strategic collaboration with BobcatBio, a clinical-stage biotechnology company that is pioneering the development of RB-1355, a first of its kind cellular therapy that leverages the versatility and power of a patient...
read more
MedPharm reported that it is supporting Palvella Therapeutics following Palvella’s announcement of positive topline results from the Phase 3 SELVA study of QTORIN 3.9% rapamycin anhydrous gel in microcystic lymphatic malformations (microcystic LMs).
read more
BioCina announced it has initiated a comprehensive CMC (Chemistry, Manufacturing, and Controls) program for the advancement of RLS-2201, a proprietary injectable formulation of Quetiapine being developed by Patrys for the acute treatment of delirium ...
read more
AptarGroup announced that its proprietary nasal delivery system is being utilized in LTR Pharma Limited’s Phase II clinical study of SPONTAN®, an investigational intranasal spray under development for the treatment of erectile dysfunction.
read more
Piramal Pharma Solutions (PPS) announced that its Grangemouth, UK facility has completed production of its 1,500th antibody-drug conjugate (ADC) batch. The milestone batch represents a commercial oncology product.
read more
Biologos announced the appointment of Hetal Patel as Chief Executive Officer. The announcement coincides with Biologos’ 50th anniversary and follows significant recent investments in facilities and capabilities to support customers across biopharma, ...
read more
LabConnect announced the grand opening of its new facility in Wuxi, China. Together with LabConnect's laboratory capabilities in Australia, the new site strengthens the company's ability to support multi-regional clinical trials while helping Asia-...
read more
Breckenridge Pharmaceutical, the U.S. subsidiary of Towa International, announced a partnership with Maiva Pharma focused on sterile injectable products to be supplied primarily to hospitals and clinics.
read more
Trenchant BioSystems and Invetech have entered into a strategic alliance which will collaborate on the continued development of Trenchant’s fully automated AutoCell Platform, intended for future commercialization.
read more
Kindeva announced the appointment of Mike Cowhig to the role of Chief Legal Officer, to drive legal strategy, enterprise risk management and corporate governance across the organization.
read more
Naobios and SGS announce their partnership in the manufacturing of a Respiratory Syncytial Virus (RSV) challenge agent for use in Controlled Human Infection Model (CHIM) studies conducted by SGS.
read more
Neuland Laboratories will open its new commercial peptide facility in the summer of 2026 at its 17-acre Bonthapally manufacturing campus, with further capacity expansions planned as client demand increases. The first of four planned modules is ...
read more
Lonza has entered into a definitive agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds for an enterprise value of CHF 2.3 billion (USD 3 billion). Lonza will realize upfront cash proceeds of CHF 1.7 billion (USD 2...
read more